Please note: The information displayed on this page might be outdated.
Notch Therapeutics: Notch is an immune cell therapy company creating universally compatible, allogeneic (off-the-shelf) T cell therapies for the treatment of cancer and immune disorders. Notch’s technology platform uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and has the potential to deliver safer, consistently manufactured and more cost-effective cell immunotherapies to patients. At the core of Notch’s technology is the synthetic Engineered Thymic Niche (ETN) platform, which precisely controls the expansion and differentiation of stem cells in a process suitable for large-scale manufacturing, delivering fully defined, consistent, feeder-free and serum-free T cells that can be genetically tailored for any T cell-based immunotherapeutic application.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
North America
Disease Space
Immuno-Oncology
Listing
Private
Therapeutic Modalities
Cell Therapy
Website:
Address:
2405 Wesbrook Mall
4th Floor
Vancouver, BC V6T 1Z3
Canada

Company Participants at Summer 2020 NYC Private Company Showcase

  • David J. Main, CEO

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Summer 2020 NYC Private Company Showcase

New York, NY, August 10, 2020